Mizuho Securities USA’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57M Buy
17,001
+3,658
+27% +$1.36M 0.11% 168
2026
Q1
$3.91M Sell
13,343
-2,839
-18% -$933K 0.09% 246
2025
Q4
$5.47M Sell
16,182
-218
-1% -$73.7K 0.09% 187
2025
Q3
$5.23M Buy
16,400
+785
+5% +$244K 0.11% 190
2025
Q2
$6.07M Sell
15,615
-2,955
-16% -$1.19M 0.13% 158
2025
Q1
$8.08M Sell
18,570
-3,411
-16% -$1.37M 0.17% 113
2024
Q4
$8.11M Buy
21,981
+6,944
+46% +$2.91M 0.15% 126
2024
Q3
$7.82M Sell
15,037
-2,885
-16% -$1.54M 0.17% 98
2024
Q2
$9.71M Buy
+17,922
New +$9.47M 0.21% 85
2017
Q1
Sell
-9,400
Closed -$1.35M 181
2016
Q4
$1.35M Buy
+9,400
New +$1.26M 0.06% 97

Other funds holding ELV

Mizuho Securities USA's ELV Position: Q2 2026 in Review

Mizuho Securities USA increased its Elevance Health (ELV) stake by 27% in Q2 2026, buying an estimated $1.36M and bringing the position to 17,001 shares worth $6.57M. The position accounts for 0.11% of the portfolio, ranked #168.

Mizuho Securities USA first reported a position in ELV in Q4 2016 and has held it in 10 quarters since. The position peaked at $9.71M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Mizuho Securities USA held 17,001 shares of Elevance Health worth $6.57M as of Q2 2026.
  • Mizuho Securities USA bought 3,658 Elevance Health shares in Q2 2026, an estimated $1.36M.
  • Elevance Health made up 0.11% of Mizuho Securities USA's portfolio in Q2 2026, its #168 holding.
  • Mizuho Securities USA first reported a position in Elevance Health in Q4 2016 and has held it in 10 quarters since.
  • Mizuho Securities USA's Elevance Health position peaked at $9.71M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.